GOLDMAN SACHS GROUP INC - ICU MED INC ownership

ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 271 filers reported holding ICU MED INC in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ICU MED INC
ValueSharesWeighting
Q3 2023$2,214,151
-52.5%
18,605
-28.8%
0.00%
-100.0%
Q2 2023$4,658,911
+30.2%
26,146
+20.6%
0.00%0.0%
Q1 2023$3,577,446
-26.9%
21,687
-30.2%
0.00%0.0%
Q4 2022$4,891,919
+38.4%
31,064
+32.4%
0.00%0.0%
Q3 2022$3,534,000
-21.1%
23,466
-13.9%
0.00%0.0%
Q2 2022$4,481,000
-40.1%
27,257
-18.8%
0.00%
-50.0%
Q1 2022$7,478,000
+4.1%
33,583
+11.0%
0.00%
+100.0%
Q4 2021$7,183,000
-9.6%
30,260
-11.1%
0.00%
-50.0%
Q3 2021$7,946,000
+37.6%
34,048
+21.4%
0.00%
+100.0%
Q2 2021$5,774,000
-5.7%
28,055
-5.9%
0.00%
-50.0%
Q1 2021$6,125,000
+4.6%
29,816
+9.3%
0.00%0.0%
Q4 2020$5,853,000
-34.8%
27,284
-44.4%
0.00%
-33.3%
Q3 2020$8,976,000
-0.2%
49,108
+0.7%
0.00%0.0%
Q2 2020$8,990,000
-19.0%
48,778
-11.3%
0.00%
-25.0%
Q1 2020$11,094,000
+10.9%
54,986
+2.8%
0.00%
+33.3%
Q4 2019$10,006,000
-4.0%
53,470
-18.1%
0.00%0.0%
Q3 2019$10,425,000
-49.2%
65,317
-19.9%
0.00%
-50.0%
Q2 2019$20,537,000
+0.7%
81,525
-4.3%
0.01%0.0%
Q1 2019$20,397,000
+13.2%
85,227
+8.6%
0.01%0.0%
Q4 2018$18,019,000
-44.0%
78,469
-31.0%
0.01%
-25.0%
Q3 2018$32,149,000
-48.0%
113,701
-46.0%
0.01%
-52.9%
Q2 2018$61,805,000
+16.3%
210,473
-0.0%
0.02%
+21.4%
Q1 2018$53,139,000
-33.0%
210,536
-42.7%
0.01%
-26.3%
Q4 2017$79,313,000
+11.4%
367,188
-4.1%
0.02%
+11.8%
Q3 2017$71,166,000
+6.2%
382,925
-1.4%
0.02%0.0%
Q2 2017$67,012,000
+17.3%
388,473
+3.8%
0.02%
+6.2%
Q1 2017$57,141,000
+21.4%
374,203
+17.1%
0.02%
+23.1%
Q4 2016$47,070,000
+283.0%
319,447
+228.5%
0.01%
+225.0%
Q3 2016$12,290,000
+119.9%
97,245
+96.2%
0.00%
+100.0%
Q2 2016$5,588,000
-51.1%
49,562
-54.9%
0.00%
-50.0%
Q1 2016$11,430,000
+140.9%
109,790
+160.9%
0.00%
+300.0%
Q4 2015$4,745,000
-42.0%
42,074
-43.7%
0.00%
-66.7%
Q3 2015$8,184,000
+1.2%
74,738
-11.6%
0.00%0.0%
Q2 2015$8,086,000
+21.5%
84,532
+18.3%
0.00%
+50.0%
Q1 2015$6,654,000
-2.3%
71,441
-14.1%
0.00%0.0%
Q4 2014$6,811,000
+146.2%
83,171
+93.0%
0.00%
+100.0%
Q3 2014$2,766,000
+30.2%
43,093
+23.3%
0.00%0.0%
Q2 2014$2,124,000
+342.5%
34,941
+336.1%
0.00%
Q1 2014$480,000
-93.3%
8,013
-92.9%
0.00%
-100.0%
Q4 2013$7,210,000
+50.5%
113,178
+60.5%
0.00%0.0%
Q3 2013$4,791,000
+226.1%
70,533
+246.1%
0.00%
+100.0%
Q2 2013$1,469,000
-23.1%
20,382
-35.0%
0.00%0.0%
Q4 2012$1,911,000
-2.3%
31,362
-3.0%
0.00%0.0%
Q3 2012$1,956,000
+84.0%
32,338
+62.4%
0.00%
Q2 2012$1,063,000
+61.8%
19,907
+49.1%
0.00%
Q1 2012$657,00013,3540.00%
Other shareholders
ICU MED INC shareholders Q2 2021
NameSharesValueWeighting ↓
EVR Research LP 22,000$4,719,0003.86%
NUANCE INVESTMENTS, LLC 901,483$193,359,0003.73%
Nitorum Capital, L.P. 417,241$89,494,0003.46%
Tamarack Advisers, LP 73,000$15,452,0003.22%
PFM Health Sciences, LP 267,817$57,444,0002.02%
KIRR MARBACH & CO LLC /IN/ 22,222$4,766,0001.49%
PURA VIDA INVESTMENTS, LLC 174,399$37,407,0001.36%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 2,584$554,0000.88%
Findlay Park Partners LLP 528,825$113,428,0000.79%
Altium Capital Management LP 9,321$1,999,0000.75%
View complete list of ICU MED INC shareholders